Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo
- 1 May 1997
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 57 (1-2) , 231-241
- https://doi.org/10.1016/s0091-3057(96)00354-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate NeuronsAnnual Review of Physiology, 1995
- Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Muscarinic M1-Receptor AgonistsCNS Drugs, 1995
- The Diversity of Neuronal Nicotinic Acetylcholine ReceptorsAnnual Review of Neuroscience, 1993
- The fall and rise of neuronal α-bungarotoxin binding proteinsTrends in Pharmacological Sciences, 1992
- Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptorsTrends in Pharmacological Sciences, 1991
- Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeysNeurobiology of Aging, 1991
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalisAnnals of Neurology, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973